跳至主要内容
临床试验/NCT01669265
NCT01669265已完成不适用

Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast Cancer

SOLTI Breast Cancer Research Group9 个研究点 分布在 1 个国家目标入组 701 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
701
试验地点
9
主要终点
Estimate the negative predictive value of the technique OSNA.

研究概览

简要总结

This is a retrospective, multicentric cohort study of patient cases with cT1-3, N0 early breast cancer, who previously had intraoperative sentinel lymph node (SLN) evaluation by one-step nucleic acid amplification (OSNA) assay with a complete axillary dissection.

The aim of the present study is to assess the intraoperative positive SLN total tumor load (TTL) obtained from the OSNA assay and to determine whether this TTL predicts non-SLN metastasis in patients with clinically node-negative early-stage breast cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Pathologically confirmed invasive breast carcinoma
  • Stage T1-3,N0 evaluated by physical exam or imaging according to AJCC v.7 and best clinical local practices
  • Intraoperative evaluation of sentinel lymph node (SLN) by OSNA
  • Complete dissection of axillary lymph nodes after the evaluation of the SLNs by OSNA
  • Pathology report of the tumor and dissected lymph nodes that includes the following information:
  • primary tumor size (mm), tumor grade (Scarff-Bloom Richardson), estrogen receptor status
  • progesterone receptor status
  • HER2 status (ASCO/CAP guidelines)
  • Ki67 index
  • presence/absence of lymphovascular invasion
  • total number of sentinel and non-sentinel lymph nodes dissected during surgery
  • total number of positive and negative sentinel and non-sentinel lymph nodes, *size of the metastasis in both sentinel and non-sentinel lymph nodes
  • total tumoral load in each sentinel lymph node, expressed as number of CK19 mRNA copies per microliter.

排除标准

  • Patients who underwent neoadjuvant chemotherapy
  • CK19-negative breast tumor
  • ALND with <10 lymph nodes
  • In situ carcinoma only
  • Metastatic breast cancer at time of diagnosis

结局指标

主要结局

Estimate the negative predictive value of the technique OSNA.

时间窗: At time of surgery

Estimate the negative predictive value of the technique OSNA for the cutoff point that maximizes (tentatively, 10,000 to 15,000 copies / uL) of axillary lymph node involvement in breast cancer early N0.

次要结局

  • ROC curve that describes the assay(At time of surgery)
  • Sensitivity of the assay(At time of surgery)
  • Specificity of the assay(At time of surgery)
  • Likelihood ratio for the cutoff of 10,000-15,000 copies/uL(At time of surgery)
  • Positive predictive value at the cutoff of 10.000-15.000 copies/μL.(At time of surgery)

研究者

发起方
SOLTI Breast Cancer Research Group
申办方类型
Other
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验